UPDATE: JPMorgan Upgrades Qiagen NV (QGEN) to Overweight

Go back to UPDATE: JPMorgan Upgrades Qiagen NV (QGEN) to Overweight

Thermo Fisher Scientific (TMO) Potential Deal for Qiagen (QGEN) Good Up to $50/Share - Wolfe Research

November 14, 2019 8:54 AM EST

Wolfe Research analyst Steve Beuchaw said he likes the rumored /Thermo Fisher Scientific (NYSE: TMO)/Qiagen (NYSE: QGEN) deal up to $50 per share.

The analyst notes comparable companies have traded at 18-20x trailing EBITDA (implies... More